Helixmith Co., Ltd.
19 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A 6-Month Extension Study of VMDN-003-2 to Assess Engensis in Participants With Painful Diabetic Peripheral Neuropathy (NCT04873232) | Helixmith Co., Ltd. | 2021-05-17 |
| The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19 (NCT05552625) | Helixmith Co., Ltd. | 2021-05-06 |
| Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis (NCT04632225) | Helixmith Co., Ltd. | 2021-03-09 |
| Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy (NCT04469270) | Helixmith Co., Ltd. | 2020-11-20 |
| The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A) (NCT05361031) | Helixmith Co., Ltd. | 2020-09-21 |
| Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea (NCT03404024) | Helixmith Co., Ltd. | 2018-01-25 |
Track Helixmith Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.